Literature DB >> 31934970

Pediatric-Specific Midfacial Fracture Patterns and Management: Pediatric Versus Adult Patients.

Kou Fujisawa1, Ayumi Suzuki, Tomomi Yamakawa, Fumio Onishi, Toshiharu Minabe.   

Abstract

PURPOSE: The purpose of this study was to compare the midfacial fracture patterns and management approaches between pediatric and adult patients.
METHODS: We retrospectively analyzed 164 pediatric patients (<16 years old) and 564 nongeriatric adult patients (16 to 65 years old) with midfacial fractures at a single institution between 2011 and 2016. The location of the fractures, along with the etiology and management of the midfacial fractures, were compared.
RESULTS: Significantly greater proportions of pediatric versus adult patients had sports-related injuries (P < 0.001) and sustained nasal fractures (P < 0.001). On the other hand, significantly greater proportions of adult versus pediatric patients were injured in falls, traffic accidents, or assaults (P = 0.004, P < 0.001, and P = 0.002) and sustained maxillary or zygomatic fractures (P = 0.039 and P < 0.001). Bivariate logistic regression analyses revealed that the risks of nasal, maxillary, and zygomatic fractures were significantly related to age status after adjusting for etiology (P < 0.001, P = 0.045, and P < 0.001). In contrast, the risks of hospitalization and surgical treatment were significantly associated with etiology, but not with age status (P = 0.290 and P = 0.847).
CONCLUSION: These data suggest that the age-related structure and composition of the facial skeleton affect the pediatric-specific fracture patterns independent of the etiology. The comparisons in this study may serve as a guide for the management of pediatric midfacial fractures.

Entities:  

Mesh:

Year:  2020        PMID: 31934970     DOI: 10.1097/SCS.0000000000006166

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  1 in total

1.  Effects of the COVID-19 Pandemic on Pediatric Nasal Fractures.

Authors:  Cigdem Firat Koca; Turgut Celik; Sukru Aydin; Mehmet Kelles; Seyma Yasar
Journal:  Ear Nose Throat J       Date:  2021-11-23       Impact factor: 1.677

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.